| 000 | 01556 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512084119.0 | ||
| 264 | 0 | _c19850927 | |
| 008 | 198509s 0 0 eng d | ||
| 022 | _a0012-6578 | ||
| 024 | 7 |
_a10.1177/106002808501900714 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElenbaas, R M | |
| 245 | 0 | 0 |
_aSubcutaneous epinephrine vs. nebulized metaproterenol in acute asthma. _h[electronic resource] |
| 260 |
_bDrug intelligence & clinical pharmacy _c |
||
| 300 |
_a567-71 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAerosols |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aEpinephrine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetaproterenol _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPeak Expiratory Flow Rate |
| 700 | 1 | _aFrost, G L | |
| 700 | 1 | _aRobinson, W A | |
| 700 | 1 | _aCollier, R E | |
| 700 | 1 | _aMcNabney, W K | |
| 700 | 1 | _aRyan, J L | |
| 700 | 1 | _aSingsank, M J | |
| 773 | 0 |
_tDrug intelligence & clinical pharmacy _gvol. 19 _gno. 7-8 _gp. 567-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/106002808501900714 _zAvailable from publisher's website |
| 999 |
_c4034646 _d4034646 |
||